FreeTheAI

Newron Pharmaceuticals S.p.A.

NWRN · BX · CHF

NWRN Price chart 6M
Open
—
Day range
—
52-week range
—
Volume
—
Market cap
184.1M
P/E ratio
—
EPS
-1.67
Dividend yield
0.00%
Beta
1.73

In the news

  1. Oct 8

    Newron Pharmaceuticals Receives FDA Feedback on US Clinical Hold for Schizophrenia Drug Study

    Newron Pharmaceuticals received FDA feedback on its U.S. clinical hold for ENIGMA-TRS 2, while ENIGMA-TRS 1 data is expected in Q1 2027.

    Company news

  2. Oct 8

    Newron Pharmaceuticals FDA Clinical Hold Remains in Place Over Safety Concerns

    Newron Pharmaceuticals reports that an FDA clinical hold on its ENIGMA-TRS 2 trial remains active as the regulator reviews safety data.

    Company news

Embed on your site

Embed docs

Add a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.

<iframe src="https://stocks.freetheai.org/embed/BX-NWRN" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Newron Pharmaceuticals S.p.A. (NWRN) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/BX-NWRN">NWRN stock price</a> by FreeTheAI Stocks</p>